ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    Utilization of Subacute Rehabilitation Facility Early After Kidney Transplantation.

    F. Luan, M. Ben-Israel, S. Mulgaonkar.

    Sanit Barnabas Medical Center, Livingston, NJ.

    Introduction: Although kidney transplantation is lifesaving compared to dialysis the relative risk for death is higher early after the surgery. Appropriate perioperative management could mitigate…
  • 2016 American Transplant Congress

    Cytomegalovirus Infection After Cardiac Transplantation.

    O. Kiamanesh, A. Khosla, C. Imai, E. Johansson, S. Virani, M. Davis, A. Cheung, J. Bashir, B. Munt, A. Ignaszewski, A. Kaan, M. Toma.

    University of British Columbia, Vancouver, Canada.

    BackgroundOrthotopic heart transplantation (OHT) continues to be the gold standard for the management of patients with end-stage heart failure. However, complications following OHT may result…
  • 2016 American Transplant Congress

    Prophylactic Anti-Virus Therapy, Is It Necessary to Occult Hepatitis B Virus Carriers with HBsAg(-) and HBcAb(+) After Kidney Transplantation?

    G. Chen, C. Wang, L. Chen, J. Qiu, C. Wang.

    Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.

    Background Hepatitis B virus(HBV) infection is common among uremia patients in China. Many patients received kidney transplantation are occult HBV carriers with HBsAg(-) and HBcAb(+)…
  • 2016 American Transplant Congress

    Posttransplant AT1Rabs Precede De Novo HLA-DSA Development.

    J. Arreola-Guerra,3 E. Cuevas,1 E. Hernandez-Mendez,1 M. Vilatoba,1 A. Contreras,1 J. Ramirez,1 D. de Rongs,1 J. Granados,1 L. Morales-Buenrostro,2 J. Alberu.1

    1Transplantation, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; 2Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; 3Tranplantation, Instituto de Servicios de Salud del Estado de Aguascalientes, Aguascalientes, Mexico.

    Angiotensin II type 1 receptor antibodies (AT1Rabs) have been associated with acute allograft rejection and graft loss. The possible implication of the generation of de…
  • 2016 American Transplant Congress

    Expansion of Anti-HLA Antibodies After Renal Transplantation and Prognosis in Those Which Fix C1q.

    P. Ruiz-Esteban,1 M. Gonzalez-Molina,1 A. Caballero,2 A. Torio,2 M. Leon,3 E. Palma,1 D. Burgos,1 M. Cabello,1 V. Lopez,1 M. Rodriguez,4 D. Hernandez.1

    1Nephrology, Regional University Hospital, IBIMA, University of Malaga, Malaga, Spain; 2Immunology, Regional University Hospital, IBIMA, University of Malaga, Malaga, Spain; 3Pathology, Regional University Hospital, IBIMA, University of Malaga, Malaga, Spain; 4Nephrology, Torrecardenas Hospital, Almeria, Spain.

    Introduction. Antibody-mediated rejection (ABMR) is the major cause of allograft failure. We studied the evolution and prognostic effect of pre-formed and de novo anti-HLA antibodies…
  • 2016 American Transplant Congress

    In Vitro and In Vivo Characterization of Human Hematopoietic Chimeric Cells – A Novel Approach for Tolerance Induction in Transplantation.

    M. Siemionow, E. Tfaily, M. Cyran, R. Gendek, M. Strojny, E. Szilagyi, J. Cwykiel.

    Department of Orthopaedics, University of Illinois at Chicago, Chicago, IL.

    Background: Cell-based therapies represent a new promising approach for tolerance induction in transplantation. One of the methods for immune response modulation in solid organ and…
  • 2016 American Transplant Congress

    Human Multipotent Mesenchymal Stromal Cells Improve Survival and Function of Pancreatic Islets by Cell-to-Cell Contact.

    E. Montanari,1 R. Meier,2 D. Bosco,1 R. Mahou,3 P. Morel,2 J. Seebach,4 C. Wandrey,3 C. Gonelle-Gispert,1 L. Bühler.2

    1University of Geneva, Geneva, Switzerland; 2Division of Digestive and Transplantation Surgery, University Hospitals of Geneva, Geneva, Switzerland; 3Institut d'Ingénierie Biologique et Institut des Sciences et Ingénierie Chimiques, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland; 4Division of Immunology and Allergy, University Hospitals of Geneva, Geneva, Switzerland.

    Background: MSC exhibit immunomodulatory and anti-inflammatory properties. Notably, MSC were shown to preserve human islet function and to prevent cytokine-induced apoptosis. Aim: To evaluate the…
  • 2016 American Transplant Congress

    Necroptosis Is Involved in CD4+ T-Cell Mediated Microvascular Endothelial Cell Death and Chronic Cardiac Allograft Rejection.

    C. Kwok,1,2 N. Montwill,1,2 A. Pavlosky,1,2 A. Haig,2 X.-Y. Huang,1 A. Jevnikar,1,3 Z.-X. Zhang.1,2,3

    1Matthew Mailing Centre for Translational Transplant Studies, London Health Sciences Centre, London, Canada; 2Department of Pathology and Laboratory Medicine, Western University, London, Canada; 3Department of Medicine, Western University, London, Canada.

    Heart transplantation is potentially the only viable option for patients with end-stage heart failure. Despite advances in immunosuppressive therapies, cardiac allograft chronic rejection is a…
  • 2016 American Transplant Congress

    Acquired Down-Regulation of B Cell Function Induced by Donor Blood Group Antigens After ABO-Incompatible Kidney Transplantation.

    M. Tasaki,1 K. Saito,1 Y. Nakagawa,1 N. Imai,2 T. Aoki,3 M. Kamimura,3 K. Takahashi,1 Y. Tomita.1

    1Division of Urology, Department of Regenerative & Transplant Medicine, Niigata Graduate School of Medical and Dental Sciences, Niigata, Japan; 2Division of Clinical Nephrology and Rheumatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan; 3Division of Transfusion Medicine and Regenerative Medicine Bioscience Medical Center, Niigata University Medical and Dental Hospital, Niigata, Japan.

    Background: The long-term of B cell immunobiology against donor blood group antigen has not been elucidated in ABO incompatible kidney transplantation (ABOi KTx).Methods: The antibody…
  • 2016 American Transplant Congress

    Analysis of a Large Single-Center Cohort of Renal Transplant Recipients with Histoplasmosis.

    M. Mashayekhi, A. Langone.

    Internal Medicine, Vanderbilt University Medical Center, Nashville, TN.

    The dimorphic fungus Histoplasma capsulatum is endemic along the Ohio and Mississippi River Valleys and can cause clinically significant disease in those with impaired cellular…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences